Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 7
1974 1
1975 5
1976 5
1977 6
1978 3
1979 1
1980 2
1981 2
1982 3
1983 4
1984 3
1985 4
1986 5
1987 8
1988 6
1989 7
1990 15
1991 9
1992 4
1993 8
1994 7
1995 4
1996 9
1997 9
1998 11
1999 7
2000 9
2001 4
2002 9
2003 10
2004 8
2005 4
2006 4
2007 2
2008 5
2009 7
2010 13
2011 9
2012 12
2013 6
2014 3
2015 6
2016 5
2017 4
2018 3
2019 4
2020 6
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Results by year
Filters applied: . Clear all
Page 1
Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
Nardi AE, Freire RC, Valença AM, Amrein R, de Cerqueira AC, Lopes FL, Nascimento I, Mezzasalma MA, Veras AB, Sardinha A, de Carvalho MR, da Costa RT, Levitan MN, de-Melo-Neto VL, Soares-Filho GL, Versiani M. Nardi AE, et al. J Clin Psychopharmacol. 2010 Jun;30(3):290-3. doi: 10.1097/JCP.0b013e3181dcb2f3. J Clin Psychopharmacol. 2010. PMID: 20473065 Clinical Trial.
High-potency benzodiazepines, such as clonazepam, are frequently used in the treatment of panic disorder (PD) because of their rapid onset of action and good tolerability. ...We recommend reducing the dosage of clonazepam after intermediate-term use by 0.25 mg/wk... …
High-potency benzodiazepines, such as clonazepam, are frequently used in the treatment of panic disorder (PD) because of their rapid …
Oral clonazepam versus lorazepam in the treatment of methamphetamine-poisoned children: a pilot clinical trial.
Farnaghi F, Rahmani R, Hassanian-Moghaddam H, Zamani N, McDonald R, Gholami N, Gachkar L. Farnaghi F, et al. BMC Pediatr. 2020 Dec 3;20(1):543. doi: 10.1186/s12887-020-02441-x. BMC Pediatr. 2020. PMID: 33267837 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy of oral clonazepam versus oral lorazepam following initial parenteral benzodiazepine administration to control methamphetamine-induced agitation in children. ...There was no report of benzodiazepine complications in either group. CONCLU …
OBJECTIVES: To evaluate the efficacy of oral clonazepam versus oral lorazepam following initial parenteral benzodiazepine administrat …
The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial.
Herman CR, Schiffman EL, Look JO, Rindal DB. Herman CR, et al. J Orofac Pain. 2002 Winter;16(1):64-70. J Orofac Pain. 2002. PMID: 11889661 Clinical Trial.
All subjects were given education about TMD and a self-care program. Subjects were randomized into 1 of 3 groups: clonazepam (0.5 mg/night), cyclobenzaprine (10 mg/night), or placebo. ...CONCLUSION: This study suggests that cyclobenzaprine is statistically superior to eith …
All subjects were given education about TMD and a self-care program. Subjects were randomized into 1 of 3 groups: clonazepam (0.5 mg/ …
Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures.
Mikkelsen B, Birket-Smith E, Bradt S, Holm P, BParm, Lung M, Thorn I, Vestermark S, Olsen PZ. Mikkelsen B, et al. Arch Neurol. 1976 May;33(5):322-5. doi: 10.1001/archneur.1976.00500050008002. Arch Neurol. 1976. PMID: 817696 Clinical Trial.
The effects of the combined use of clonazepam and the previous antiepileptid drugs were compared with the effects of placebo combined with the same drugs. ...Mental sideeffects such as agitation, confusion, and aggressiveness were more troublesome and caused discontinuatio …
The effects of the combined use of clonazepam and the previous antiepileptid drugs were compared with the effects of placebo combined …
Clonazepam.
Browne TR. Browne TR. N Engl J Med. 1978 Oct 12;299(15):812-6. doi: 10.1056/NEJM197810122991505. N Engl J Med. 1978. PMID: 99652 Clinical Trial. No abstract available.
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, de Carvalho MR, de Cerqueira AC, Hallak JE, Crippa JA, Versiani M. Nardi AE, et al. Braz J Med Biol Res. 2011 Apr;44(4):366-73. doi: 10.1590/s0100-879x2011007500020. Epub 2011 Feb 18. Braz J Med Biol Res. 2011. PMID: 21344132 Free article. Clinical Trial.
Anxiety severity was significantly reduced with clonazepam versus paroxetine at weeks 1 and 2, with no difference in panic disorder severity. Patients treated with clonazepam had fewer adverse events than patients treated with paroxetine (73 vs 95%; P = 0.001). ...
Anxiety severity was significantly reduced with clonazepam versus paroxetine at weeks 1 and 2, with no difference in panic disorder s …
An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder.
Ferri R, Marelli S, Ferini-Strambi L, Oldani A, Colli F, Schenck CH, Zucconi M. Ferri R, et al. Sleep Med. 2013 Jan;14(1):24-9. doi: 10.1016/j.sleep.2012.09.009. Epub 2012 Oct 23. Sleep Med. 2013. PMID: 23098778 Clinical Trial.
OBJECTIVE: To analyze the differences in sleep structure and nocturnal motor activity between drug-free REM sleep behavior disorder (RBD) patients and those under therapy with clonazepam, and to evaluate the long-term longitudinal changes under continued therapy with cl
OBJECTIVE: To analyze the differences in sleep structure and nocturnal motor activity between drug-free REM sleep behavior disorder (RBD) pa …
Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: A randomized placebo-controlled trial.
Shin C, Park H, Lee WW, Kim HJ, Kim HJ, Jeon B. Shin C, et al. J Neurol Sci. 2019 Jun 15;401:81-86. doi: 10.1016/j.jns.2019.04.029. Epub 2019 Apr 23. J Neurol Sci. 2019. PMID: 31035190 Clinical Trial.
The primary outcome was the Clinical Global Impressions-Improvement (CGII) score at week four, and we compared scores between the clonazepam and placebo groups. RESULTS: A total of 40 patients were enrolled, with 20 assigned to receive clonazepam and 20 to receive t …
The primary outcome was the Clinical Global Impressions-Improvement (CGII) score at week four, and we compared scores between the clonaze
Clonazepam: a review of open clinical trials.
Pollack MH. Pollack MH. J Clin Psychiatry. 1987 Oct;48 Suppl:12-5. J Clin Psychiatry. 1987. PMID: 3312178 Review.
Data were collected on 50 patients with panic attacks who were treated with clonazepam to determine the drug's antipanic efficacy. At a mean duration of 54.3 weeks, 62% of the patients remained in treatment and 38% were lost to follow-up. Of those remaining in treatment, 9 …
Data were collected on 50 patients with panic attacks who were treated with clonazepam to determine the drug's antipanic efficacy. At …
275 results